Loading
QP
Quest PharmaTech Inc. Stock: price and insider trades · Canada
Quest PharmaTech Inc.: what insiders have been doing
Every trade that managers of Quest PharmaTech Inc. disclose to SEDI is tracked on this page. The company sits in the Health Care sector. Nothing new has been filed by managers of Quest PharmaTech Inc. in twelve months, the latest record being from 23 July 2025.
Our records for Quest PharmaTech Inc. go back to 2017, with 5 purchases and no sales on the open market in total.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
22
Thresholds
n/a
Buy Volume
€13,695
5 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended January 2026 · cache
CA$0.02
Analyst consensus
Income statement
EBITDACA$5M
Net incomeCA$5M0.0% margin
Valuation
PER (trailing)0.7x
P/Book0.1x
Beta-0.46
Balance sheet & cash
Market capCA$3.4M
Total debtCA$1M
Free Cash Flow-CA$190.7k
Debt / Equity4%
Profitability & ownership
ROE20.0%
ROA-1.7%
% insiders16.9%
% institutions0.0%
Last declaration on 23 July 2025
Declarations22 total
700,000 shares@ CA$0.0425.0% of flowCommon SharesTSXSEDI:4550244
300,000 shares@ CA$0.0410.7% of flowCommon SharesTSXSEDI:4550246
1,000,000 shares@ CA$0.0435.6% of flowCommon SharesTSXSEDI:4550240
Common SharesTSXSEDI:4550242
8,000 shares@ CA$0.07Common SharesTSXSEDI:4180210
Canonical exit: 5 Dec 2023 (T+90)
20,000 shares@ CA$0.070.6% of flowCommon SharesTSXSEDI:4174244
Canonical exit: 23 Nov 2023 (T+90)
30,000 shares@ CA$0.070.8% of flowCommon SharesTSXSEDI:4172928
Canonical exit: 20 Nov 2023 (T+90)
45,000 shares@ CA$0.109.8% of flowCommon SharesTSXSEDI:3932365
400,000 shares@ CA$0.1017.3% of flowCommon SharesTSXSEDI:3932384
Common SharesTSXSEDI:3774449
50,000 shares@ CA$0.10100.0% of flowCommon SharesTSXSEDI:3488568
150,000 shares@ CA$0.1034.2% of flowCommon SharesTSXSEDI:3485305
10,000 shares@ CA$0.165100.0% of flowCommon SharesTSXSEDI:3365646
Canonical exit: 1 May 2019 (T+90)
Common SharesTSXSEDI:3365631
Common SharesTSXSEDI:3308258
300,000 shares@ CA$0.1028.7% of flowCommon SharesTSXSEDI:3250672
Common SharesTSXSEDI:3197508
150,000 shares@ CA$0.1033.3% of flowCommon SharesTSXSEDI:3043111
1,666,667 shares@ CA$0.10100.0% of flowCommon SharesTSXSEDI:3043127
1,000,000 shares@ CA$0.1048.8% of flowCommon SharesTSXSEDI:3043130
Common SharesTSXSEDI:3039260
112,500 shares@ CA$0.13100.0% of flowCommon SharesTSXSEDI:3031193
Canonical exit: 28 Sept 2017 (T+90)
22 of 22 declarations
About Quest PharmaTech Inc.
Quest PharmaTech Inc. is a biotechnology company focused on developing treatments for cancer. It is listed on the XTSE market.
